Patrick F. Smith, PRESIDENT, INTEGRATED DRUG Development at Certara, Inc. (CERT), sold 10,000 shares at $19.16 ($192K) on 2022-06-08, disclosed to the SEC on 2022-06-09.
Open-market sale of $192k CERT by PRESIDENT, INTEGRATED DRUG Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CERT | SELL | 2024-02-21 | $90K | — | Filing → |
| CERT | SELL | 2023-06-06 | $823K | — | Filing → |
| CERT | SELL | 2022-11-14 | $32K | — | Filing → |